QiagenQGEN
13F holders, Q4 2024 (December 31)6holders
$44.57avg. 13F price*
At the end of Q4 2024, 6 institutions reported holding Qiagen N.V. (QGEN) in their 13F filings. The largest holders were Marshall Wace, LLP ($63.7M), Segall Bryant & Hamill, LLC ($6.8M) and T. Rowe Price Associates Inc. ($6.4M).
- Company
- Qiagen N.V.
- CUSIP
- N72482206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $77.0M |
| Exits | 0 | $0 |
Ownership 6 holders
| Marshall Wace, LLP | 0.08% | New | 1,428,940 | $63.7M |
| Segall Bryant & Hamill, LLC | 0.09% | New | 151,689 | $6.8M |
| T. Rowe Price Associates Inc. | 0.00% | New | 142,794 | $6.4M |
| Globeflex Capital L P | 0.01% | New | 3,400 | $151K |
| Colonial Trust Co / SC | 0.00% | New | 491 | $22K |
| Hexagon Capital Partners LLC | 0.00% | New | 94 | $4K |
"% of holder's portfolio" is QGEN's weight in each manager's 13F, not the share of Qiagen N.V. the manager owns.